Your session is about to expire
← Back to Search
SBRT After Prostatectomy for Prostate Cancer (PLUTO-MPC Trial)
PLUTO-MPC Trial Summary
This trial will study the safety and effectiveness of using SBRT to treat localized prostate cancer in patients who are also candidates for post-prostatectomy radiation.
PLUTO-MPC Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPLUTO-MPC Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PLUTO-MPC Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I cannot have intense pelvic radiation due to certain health conditions.My cancer has spread to nearby lymph nodes or other parts of my body.I have had radiation therapy to my pelvic area before.I had surgery to remove my prostate due to adenocarcinoma.
- Group 1: Men with prostate cancer post-prostatectomy
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any vacancies open in this research project for participants?
"Affirmative. On clinicaltrials.gov, the information confirms that this trial is currently recruiting participants. It was initially posted on June 3rd 2021 and revised lastly on October 25th 2022, searching for 30 patients from a single site."
How many participants are currently involved in this clinical exploration?
"Affirmative. The information hosted on clinicaltrials.gov indicates that this investigation is presently recruiting participants, having been first posted June 3rd 2021 and recently updated October 25th 2022. 30 patients need to be enrolled from a single medical centre for the study's completion."
Share this study with friends
Copy Link
Messenger